We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
-2.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$25.2B
AUM Growth
+$145M
(+0.58%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
11.42%
Holding
1,496
New
423
Increased
299
Reduced
316
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$278M |
| 2 |
Analog Devices
ADI
|
+$181M |
| 3 |
Target
TGT
|
+$172M |
| 4 |
Visa
V
|
+$150M |
| 5 |
Broadcom
AVGO
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$454M |
| 2 |
Micron Technology
MU
|
+$168M |
| 3 |
Suncor Energy
SU
|
+$146M |
| 4 |
Cheniere Energy
LNG
|
+$129M |
| 5 |
Amazon
AMZN
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.22% |
| 2 | Technology | 16.94% |
| 3 | Consumer Discretionary | 10.54% |
| 4 | Industrials | 7.2% |
| 5 | Energy | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Lear
LEA
$6.18B
| $5.71M | 0.02% |
40,029
-34,700
| -46% | -$5.64M |
|
|
ALE
652
DELISTED
Allete
ALE
| $5.67M | 0.02% |
84,702
-26,185
| -24% | -$1.68M |
|
653
SM Energy
SM
$6.96B
| $5.64M | 0.02% |
144,850
-329,571
| -69% | -$11.9M |
|
654
Federal Realty Investment Trust
FRT
$10.5B
| $5.6M | 0.02% |
45,900
+36,200
| +373% | +$4.46M |
|
655
Bread Financial
BFH
$4.54B
| $5.59M | 0.02% |
99,610
-181,100
| -65% | -$11.9M |
|
|
TVRD
656
Tvardi Therapeutics
TVRD
$18.8M
| $5.58M | 0.02% |
12,753
+2,800
| +28% | +$1.15M |
|
657
Health Catalyst
HCAT
$177M
| $5.56M | 0.02% |
+212,935
| New | +$6.04M |
|
658
CALL
Arista Networks
ANET
$248B
| $5.56M | 0.02% |
+160,000
| New | +$5.06M |
|
659
Viridian Therapeutics
VRDN
$2.33B
| $5.55M | 0.02% |
300,000
-172,864
| -37% | -$3.32M |
|
660
Keurig Dr Pepper
KDP
$41.8B
| $5.54M | 0.02% |
146,046
-668,405
| -82% | -$25.3M |
|
|
CPTN
661
DELISTED
Cepton, Inc. Common Stock
CPTN
| $5.51M | 0.02% |
+141,969
| New | +$12.7M |
|
|
SRCL
662
DELISTED
Stericycle Inc
SRCL
| $5.5M | 0.02% |
+93,375
| New | +$5.41M |
|
|
AEL
663
DELISTED
American Equity Investment Life Holding Company
AEL
| $5.5M | 0.02% |
137,792
-460,218
| -77% | -$18.5M |
|
|
ABB
664
DELISTED
ABB Ltd
ABB
| $5.46M | 0.02% |
168,839
-645,154
| -79% | -$22.5M |
|
665
PUT
NVIDIA
NVDA
$5.31T
| $5.46M | 0.02% |
+200,000
| New | +$5.02M |
|
|
NXGN
666
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $5.44M | 0.02% |
260,200
-26,000
| -9% | -$498K |
|
|
CANO
667
DELISTED
Cano Health, Inc.
CANO
| $5.41M | 0.02% |
+8,514
| New | +$5.37M |
|
|
CUTR
668
DELISTED
Cutera, Inc.
CUTR
| $5.4M | 0.02% |
78,288
-57,612
| -42% | -$2.33M |
|
669
Pliant Therapeutics
PLRX
$65M
| $5.4M | 0.02% |
770,000
-365,100
| -32% | -$3.73M |
|
670
CALL
Nike
NKE
$63B
| $5.38M | 0.02% |
+40,000
| New | +$5.62M |
|
|
APLT
671
DELISTED
Applied Therapeutics
APLT
| $5.38M | 0.02% |
2,549,000
+1,435,000
| +129% | +$3.84M |
|
672
Regal Rexnord
RRX
$12.2B
| $5.3M | 0.02% |
35,630
+4,330
| +14% | +$694K |
|
|
TSVT
673
DELISTED
2seventy bio
TSVT
| $5.3M | 0.02% |
310,700
-276,007
| -47% | -$4.68M |
|
|
TELL
674
CALL
DELISTED
Tellurian Inc.
TELL
| $5.3M | 0.02% |
+1,000,000
| New | +$3.37M |
|
675
Kinetik
KNTK
$3.56B
| $5.28M | 0.02% |
+162,470
| New | +$5.3M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Point72 Asset Management held 1,496 positions worth $25.2B, up 0.58% from $25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 Asset Management deployed $1.25B of net new capital in Q1 2022, opening 423 new positions and adding to 299 existing holdings. Its largest new stake was Target: 794,997 shares worth $169M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Micron Technology, an estimated $168M trimmed.
- Point72 Asset Management's largest Q1 2022 buy was Target: 794,997 shares worth $169M.
- Point72 Asset Management added most to Merck in Q1 2022, an estimated $278M increase.
- Point72 Asset Management's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $168M.
- Point72 Asset Management fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $454M.
- Point72 Asset Management's ten largest holdings make up 11% of its $25.2B portfolio in Q1 2022.
- Point72 Asset Management opened 423 new positions and closed 358 in Q1 2022.
- Point72 Asset Management's portfolio value rose 0.58% quarter-over-quarter to $25.2B.
Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.